Inventor · disambiguated record
Tongfei Wu
Also filed as: WU TONGFEI
27 granted patents·5 pending applications·57 citations·filing 2005–2024
94Inventor score
Files withJANSSEN PHARMACEUTICA NV18ALIGOS THERAPEUTICS INC5LEUVEN K U RES & DEV3HERDEWIJN PIET2CELLZOME LTD1
Top patents by PatentIndex Score
32 records- 0192US12018015B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·2 cites·21 claims
- 0292US11702441B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 18, 2023·2 cites·2 claims
- 0392US11059850B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 13, 2021·8 cites·21 claims
- 0491US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0590US11760761B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·26 claims
- 0690US10954214B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 23, 2021·5 cites·37 claims
- 0789US11760764B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·2 cites·24 claims
- 0885US8076310B2Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their productionHERDEWIJN PIET·Filed 2005·Granted Dec 13, 2011·14 cites·15 claims
- 0984US12145961B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Nov 19, 2024·0 cites·1 claims
- 1083US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 1180US10888550B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jan 12, 2021·3 cites·10 claims
- 1280US8809520B2Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their productionLEUVEN K U RES & DEV·Filed 2013·Granted Aug 19, 2014·3 cites·20 claims
- 1378US8501709B2Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their productionHERDEWIJN PIET·Filed 2011·Granted Aug 6, 2013·3 cites·16 claims
- 1477US9249177B2Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their productionLEUVEN K U RES & DEV·Filed 2014·Granted Feb 2, 2016·2 cites·11 claims
- 1577US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1677US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1776US11040031B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 22, 2021·2 cites·9 claims
- 1874US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1968US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 2067US8946266B2Substituted triazole and imidazole derivatives as gamma secretase modulatorsWU TONGFEI·Filed 2010·Granted Feb 3, 2015·2 cites·14 claims
- 2164US12077521B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 2264US2024277706A1Methods and compostitions for targeting pd-l1ALIGOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2361US2023241087A1Methods Of Treating Cancer Using Prmt5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2460US12428427B2Methods and compositions for targeting PD-L1ALIGOS THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·0 cites·23 claims
- 2560US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 2657US9522932B2Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their productionLEUVEN K U RES & DEV·Filed 2015·Granted Dec 20, 2016·0 cites·14 claims
- 2752US12404260B2Pyridine rings containing derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 2, 2025·0 cites·9 claims
- 2852US2015094311A1Novel substituted bicyclic heterocyclic compounds as gamma secretase modulatorsCELLZOME LTD·Filed 2014·Application pending·0 cites
- 2950US11571437B2Methods of treating cancer using PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 7, 2023·0 cites·42 claims
- 3044US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
- 3143US8946426B2Substituted bicyclic heterocyclic compounds as gamma secretase modulatorsGIJSEN HENRICUS JACOBUS MARIA·Filed 2010·Granted Feb 3, 2015·0 cites·9 claims
- 3237US8778919B2Cyclic anilino—pyridinotriazinesROMBOUTS FREDERIK JAN RITA·Filed 2006·Granted Jul 15, 2014·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Tongfei Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →